More than 31,000 units of a chemotherapy drug are being recalled by manufacturer Bristol-Myers Squibb Co., because one vial was found to be overfilled, which puts patients at risk for overdose. The recall affects 10 lots of BiCNU, an injection of the drug carmustine, which is used to treat brain tumors, multiple myeloma, Hodgkin’s disease and non-Hodgkin’s lymphoma. An overdose of BiCNU could result in lung or kidney toxicity. No adverse events have yet been reported. BiCNU was manufactured by Ben Venue Laboratories, a manufacturing contractor that Bristol-Myers Squibb no longer uses. The recall affects products sold in the United ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.